Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F37Z9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,938
Award facts
- Contract value 100% obligated
- $2,938.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $2,938.36 under a firm fixed-price, non-set-aside contract. The award was issued on November 26, 2025, with an ultimate completion date of November 28, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems.
As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through its extensive contract portfolio with the DLA Medical Supply Chain. This delivery order for Ondansetron, an antiemetic medication commonly used in military and federal healthcare settings, represents routine pharmaceutical fulfillment under the company's prime vendor agreement. The non-set-aside, competitively awarded contract reflects AmerisourceBergen's demonstrated capability to meet federal procurement standards, consistent with its established pattern of delivering both high-value and smaller-value pharmaceutical orders across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F37Z9?
SPE2DR26F37Z9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F37Z9 worth?
The government has obligated $2,938 on SPE2DR26F37Z9.
Is contract SPE2DR26F37Z9 an order under another contract?
Yes. SPE2DR26F37Z9 is a delivery order under SPE2DR25D1051, an indefinite delivery contract.
Was contract SPE2DR26F37Z9 competed?
The extent of competition for SPE2DR26F37Z9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award